Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1988 1
1989 2
1990 1
1992 1
1993 1
1994 4
1995 1
1996 1
1997 1
1998 3
1999 1
2000 4
2001 3
2003 2
2004 1
2005 4
2006 3
2008 5
2009 4
2010 3
2011 6
2012 5
2013 5
2014 6
2015 2
2016 10
2017 5
2018 3
2019 9
2020 11
2021 8
2022 14
2023 2
Text availability
Article attribute
Article type
Publication date

Search Results

127 results
Results by year
Filters applied: . Clear all
Page 1
Quantitative analysis of mRNA-1273 COVID-19 vaccination response in immunocompromised adult hematology patients.
Haggenburg S, Lissenberg-Witte BI, van Binnendijk RS, den Hartog G, Bhoekhan MS, Haverkate NJE, de Rooij DM, van Meerloo J, Cloos J, Kootstra NA, Wouters D, Weijers SS, van Leeuwen EMM, Bontkes HJ, Tonouh-Aajoud S, Heemskerk MHM, Sanders RW, Roelandse-Koop E, Hofsink Q, Groen K, Çetinel L, Schellekens L, den Hartog YM, Toussaint B, Kant IMJ, Graas T, de Pater E, Dik WA, Engel MD, Pierie CRN, Janssen SR, van Dijkman E, Poniman M, Burger JA, Bouhuijs JH, Smits G, Rots NY, Zweegman S, Kater AP, van Meerten T, Mutsaers PGNJ, van Doesum JA, Broers AEC, van Gils MJ, Goorhuis A, Rutten CE, Hazenberg MD, Nijhof IS. Haggenburg S, et al. Among authors: van binnendijk rs. Blood Adv. 2022 Mar 8;6(5):1537-1546. doi: 10.1182/bloodadvances.2021006917. Blood Adv. 2022. PMID: 35114690 Free PMC article. Clinical Trial.
SARS-CoV-2 variants of concern partially escape humoral but not T-cell responses in COVID-19 convalescent donors and vaccinees.
Geers D, Shamier MC, Bogers S, den Hartog G, Gommers L, Nieuwkoop NN, Schmitz KS, Rijsbergen LC, van Osch JAT, Dijkhuizen E, Smits G, Comvalius A, van Mourik D, Caniels TG, van Gils MJ, Sanders RW, Oude Munnink BB, Molenkamp R, de Jager HJ, Haagmans BL, de Swart RL, Koopmans MPG, van Binnendijk RS, de Vries RD, GeurtsvanKessel CH. Geers D, et al. Among authors: van binnendijk rs. Sci Immunol. 2021 May 25;6(59):eabj1750. doi: 10.1126/sciimmunol.abj1750. Sci Immunol. 2021. PMID: 34035118 Free PMC article.
The RECOVAC Immune-response Study: The Immunogenicity, Tolerability, and Safety of COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant.
Sanders JF, Bemelman FJ, Messchendorp AL, Baan CC, van Baarle D, van Binnendijk R, Diavatopoulos DA, Frölke SC, Geers D, GeurtsvanKessel CH, den Hartog G, van der Heiden M, Imhof C, Kho MML, Koopmans MPG, Malahe SRK, Mattheussens WB, van der Molen R, van Mourik D, Remmerswaal EBM, Rots N, Vart P, de Vries RD, Gansevoort RT, Hilbrands LB, Reinders MEJ; RECOVAC Collaborators. Sanders JF, et al. Among authors: van binnendijk r. Transplantation. 2022 Apr 1;106(4):821-834. doi: 10.1097/TP.0000000000003983. Transplantation. 2022. PMID: 34753894 Free PMC article.
mRNA-1273 COVID-19 vaccination in patients receiving chemotherapy, immunotherapy, or chemoimmunotherapy for solid tumours: a prospective, multicentre, non-inferiority trial.
Oosting SF, van der Veldt AAM, GeurtsvanKessel CH, Fehrmann RSN, van Binnendijk RS, Dingemans AC, Smit EF, Hiltermann TJN, den Hartog G, Jalving M, Westphal TT, Bhattacharya A, van der Heiden M, Rimmelzwaan GF, Kvistborg P, Blank CU, Koopmans MPG, Huckriede ALW, van Els CACM, Rots NY, van Baarle D, Haanen JBAG, de Vries EGE. Oosting SF, et al. Among authors: van binnendijk rs. Lancet Oncol. 2021 Dec;22(12):1681-1691. doi: 10.1016/S1470-2045(21)00574-X. Epub 2021 Nov 9. Lancet Oncol. 2021. PMID: 34767759 Free PMC article. Clinical Trial.
Immune surveillance for vaccine-preventable diseases.
den Hartog G, van Binnendijk R, Buisman AM, Berbers GAM, van der Klis FRM. den Hartog G, et al. Among authors: van binnendijk r. Expert Rev Vaccines. 2020 Apr;19(4):327-339. doi: 10.1080/14760584.2020.1745071. Epub 2020 Mar 29. Expert Rev Vaccines. 2020. PMID: 32223469 Review.
Antibody Response in Immunocompromised Patients With Hematologic Cancers Who Received a 3-Dose mRNA-1273 Vaccination Schedule for COVID-19.
Haggenburg S, Hofsink Q, Lissenberg-Witte BI, Broers AEC, van Doesum JA, van Binnendijk RS, den Hartog G, Bhoekhan MS, Haverkate NJE, Burger JA, Bouhuijs JH, Smits GP, Wouters D, van Leeuwen EMM, Bontkes HJ, Kootstra NA, Zweegman S, Kater AP, Heemskerk MHM, Groen K, van Meerten T, Mutsaers PGNJ, Beaumont T, van Gils MJ, Goorhuis A, Rutten CE, Hazenberg MD, Nijhof IS; COBRA KAI Study Team. Haggenburg S, et al. Among authors: van binnendijk rs. JAMA Oncol. 2022 Oct 1;8(10):1477-1483. doi: 10.1001/jamaoncol.2022.3227. JAMA Oncol. 2022. PMID: 35951338
Monkeys in measles research.
van Binnendijk RS, van der Heijden RW, Osterhaus AD. van Binnendijk RS, et al. Curr Top Microbiol Immunol. 1995;191:135-48. doi: 10.1007/978-3-642-78621-1_9. Curr Top Microbiol Immunol. 1995. PMID: 7789157 Review. No abstract available.
Measles seroprevalence among Dutch travelling families.
Doornekamp L, Comvalius AD, GeurtsvanKessel CH, Slobbe L, Scherbeijn SMJ, van Genderen PJJ, van Binnendijk RS, van Gorp ECM, de Swart RL, Goeijenbier M. Doornekamp L, et al. Among authors: van binnendijk rs. Travel Med Infect Dis. 2021 Nov-Dec;44:102194. doi: 10.1016/j.tmaid.2021.102194. Epub 2021 Oct 30. Travel Med Infect Dis. 2021. PMID: 34728385 Free article.
Cytotoxic T lymphocyte responses against measles virus.
UytdeHaag FG, van Binnendijk RS, Kenter MJ, Osterhaus AD. UytdeHaag FG, et al. Among authors: van binnendijk rs. Curr Top Microbiol Immunol. 1994;189:151-67. doi: 10.1007/978-3-642-78530-6_9. Curr Top Microbiol Immunol. 1994. PMID: 7924435 Review. No abstract available.
Safety and Immunogenicity of Intradermal Fractional Dose Administration of the mRNA-1273 Vaccine: A Proof-of-Concept Study.
Roozen GVT, Prins MLM, van Binnendijk R, den Hartog G, Kuiper VP, Prins C, Janse JJ, Kruithof AC, Feltkamp MCW, Kuijer M, Rosendaal FR, Roestenberg M, Visser LG, Roukens AHE. Roozen GVT, et al. Among authors: van binnendijk r. Ann Intern Med. 2022 Dec;175(12):1771-1774. doi: 10.7326/M22-2089. Epub 2022 Oct 25. Ann Intern Med. 2022. PMID: 36279543 Free PMC article. No abstract available.
127 results